This approach has been very helpful in patients who have significant weight to lose, have plateaued in their efforts, or patients in whom the additional energy is beneficial to their life situation
Sweating does not appear in clinical trial data or post-marketing surveillance reports as a direct consequence of semaglutide therapy
These side effects can be disruptive, affecting daily activities and adherence to treatment
Lexapro (escitalopram) may not be suitable for individuals with severe liver or kidney impairments, hypersensitivity to the medication, epilepsy, a history of QT interval prolongation, and more
The active ingredient in Wegovy is semaglutide which is produced using recombinant DNA technology
It oxidizes into glutathione disulfide (GSSG), where the SS denotes the disulfide bond between two glutathiones